In this study, basal levels of pERK were determined by immunocytochemical analysis and western blot analysis in order to evaluate the activation of the RAF/MEK/ERK pathway in four types of HCC cell lines with different metastatic potential. The gene discussed is MAPK1; the disease is hepatocellular carcinoma.